Controversies in the use of sentinel nodes: Microinvasion, post surgery and after preoperative systemic treatment

Paolo Veronesi, Julia Rodriguez-Fernandez, Mattia Intra

Research output: Contribution to journalArticle


In the past 10 years, sentinel lymph node biopsy (SLNB) has become a safe and accurate method for axillary staging. Several recent publications worldwide have been progressively elucidating old controversies. The list of clinical scenarios in which SLNB was initially contraindicated seems to be dwindling as experience with this technique increases. Here we discuss the suitability of SLNB in the settings of microinvasive cancer, after breast or axillary surgery and after neoadjuvant chemotherapy.

Original languageEnglish
Pages (from-to)67-70
Number of pages4
Issue number2 SUPPL.
Publication statusPublished - 2007



  • Breast cancer
  • Microinvasion
  • Primary chemotherapy
  • Prior surgery
  • Sentinel node biopsy

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this